Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Iyad Kobeissi"'
Autor:
Iyad Kobeissi, Ahmad A. Tarhini
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Cutaneous melanoma continues to increase in incidence and poses a significant mortality risk. Surgical excision of melanoma in its early stages is often curative. However, patients with resected stages IIB-IV are considered at high risk for relapse a
Externí odkaz:
https://doaj.org/article/6704324d779e44b6be84a67151ec5919
Autor:
Iyad Kobeissi, Islam Eljilany, Tala Achkar, William A. LaFramboise, Lucas Santana-Santos, Ahmad A. Tarhini
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 9; Pages: 8167
Despite the unprecedented advances in the treatment of melanoma with immunotherapy, there continues to be a major need for biomarkers of clinical benefits and immune resistance associated with immune checkpoint inhibitors; microRNA could play a vital
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad62ce23227b63ea485307794aef51f0
https://doi.org/10.3390/ijms24098167
https://doi.org/10.3390/ijms24098167
Autor:
Ahmad A. Tarhini, Brian Hobbs, Arjun Khunger, Ibrahim Yassine, Iyad Kobeissi, Patrick Hwu, Vernon K. Sondak, William LaFramboise, John M. Kirkwood
Publikováno v:
Journal of Clinical Oncology. 40:e21579-e21579
e21579 Background: A biomarker derived from the primary melanoma tumor to predict regional sentinel lymph node (SLN) metastatic status can be valuable in guiding the decision making in planning the SLN surgical procedure for candidate patients. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6dba63f6f353db93a7c62a8b6b5455b
https://doi.org/10.1200/jco.2022.40.16_suppl.e21579
https://doi.org/10.1200/jco.2022.40.16_suppl.e21579